| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Cell type-specific alterations in the nucleus accumbens by repeated exposures to cocaine.
|
Biol Psychiatry
|
2011
|
1.26
|
|
2
|
A Randomized Controlled Trial about the Levels of Radiation Exposure Depends on the Use of Collimation C-arm Fluoroscopic-guided Medial Branch Block.
|
Korean J Pain
|
2013
|
1.06
|
|
3
|
Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects.
|
Am J Cardiovasc Drugs
|
2011
|
0.90
|
|
4
|
Inhibitory networks of the amygdala for emotional memory.
|
Front Neural Circuits
|
2013
|
0.87
|
|
5
|
Fimasartan, a novel angiotensin II receptor antagonist.
|
Arch Pharm Res
|
2012
|
0.85
|
|
6
|
Pharmacological characterization of BR-A-657, a highly potent nonpeptide angiotensin II receptor antagonist.
|
Biol Pharm Bull
|
2013
|
0.82
|
|
7
|
Fimasartan, anti-hypertension drug, suppressed inducible nitric oxide synthase expressions via nuclear factor-kappa B and activator protein-1 inactivation.
|
Biol Pharm Bull
|
2013
|
0.79
|
|
8
|
Simultaneous determination of fimasartan, a novel antihypertensive agent, and its active metabolite in rat plasma by liquid chromatography-tandem mass spectrometry.
|
Biomed Chromatogr
|
2011
|
0.79
|
|
9
|
Pharmacokinetics and metabolite profiling of fimasartan, a novel antihypertensive agent, in rats.
|
Xenobiotica
|
2014
|
0.78
|
|
10
|
Comparative analysis of intracellular inhibition of hepatitis C virus replication by small interfering RNAs.
|
Biotechnol Lett
|
2010
|
0.77
|
|
11
|
BRN-103, a novel nicotinamide derivative, inhibits VEGF-induced angiogenesis and proliferation in human umbilical vein endothelial cells.
|
Bioorg Med Chem Lett
|
2011
|
0.75
|
|
12
|
Synthesis and evaluation of nicotinamide derivative as anti-angiogenic agents.
|
Bioorg Med Chem Lett
|
2013
|
0.75
|